Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Kopran Limited
KOPRAN | NSE
155.35
INR-5.84
-3.62%
KOPRAN | NSE
Loading StockChartView...
About Kopran Limited
Sector
Healthcare
Industry
Drug Manufacturers-General
Earnings date
31/03/2024
As of date
24/04/2026
Close
155.35
Open
161.15
High
162.00
Low
154.90
Kopran Limited an integrated pharmaceutical company manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms including tablets capsules dry powder suspension and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide antibacterial anticonvulsant anti-hypertensive anti-helmentics anti-histamine anti-acne anti-infective urological anti-thrombotic antidiabetic pain management gastroenterology and cardiovascular. The company was incorporated in 1958 and is headquartered in Mumbai India.
View LessKOPRAN | NSE
Risk
74.5
Sharpe
-0.65
Luna's Score
57/100
Recommendation
Hold
Luna says (KOPRAN | NSE)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
40.5%1 month
74.5%3 months
56.5%6 months
51.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
26.04
Fwd. PE
-
Price to book
2.93
Debt to equity
0.20
Debt to assets
0.13
Ent. to EBITDA
17.63
Ent. to rev.
2.51
PEG
-
Other Fundamentals
EBITDA
858.81M
MarketCap
7.49B
MarketCap(USD)
78.27M
Div. yield
0.94
Op. margin
10.25
Erngs. growth
296.60
Rev. growth
19.20
Ret. on equity
10.95
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
17.15
Range1M
58.50
Range3M
58.50
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.28
Price X volume
22.63M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 17.63 | 25.64 | Cheaper |
| Ent. to Revenue | 2.51 | 6.59 | Cheaper |
| PE Ratio | 26.04 | 41.48 | Cheaper |
| Price to Book | 2.93 | 10.46 | Cheaper |
| Dividend Yield | 0.94 | 0.96 | Par |
| Std. Deviation (3M) | 56.54 | 41.14 | Riskier |
| Debt to Equity | 0.20 | 0.14 | Expensive |
| Debt to Assets | 0.13 | 0.08 | Expensive |
| Market Cap | 7.49B | 186.70B | Emerging |
